Project Grant R43GM149069
Award Date
9/22/23
Completion Date
9/21/24
Dollars Obligated
$219K
Federal Agency
National Institute of General Medical Sciences
Awardee
Vitan-Biotech LLC (ML5NLF9L1FP9)
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Colorado, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $303,024 to Biocognon LLC to develop an innovative combinatorial pipeline for discovering nanobody-based therapeutics targeting G-protein coupled receptors (GPCRs). The key products and services to be delivered under this award include: (1) developing a robust assembly system for GPCR and nanobody libraries, (2) building a...
The National Institute of General Medical Sciences (NIGMS) awarded a $314,363 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Tango Biosciences Inc. in Chicago, Illinois. The grant supports the development of the Avidimer Platform, a novel phage display-based technology to create affinity reagents and enable high-throughput screening for identifying "molecular glues" - small molecules or biologics that induce proximity between two protein...
The National Institute of General Medical Sciences (NIGMS) awarded a $306,710 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Z Biotech, LLC to develop a glycan binding protein (GBP)-based glycosylation analysis system. The project aims to address limitations in current glycan structure analysis methods by: Collecting a large glycan array dataset to improve prediction of glycan binding affinities; Expanding coverage of glycan epitopes by supplementing with additional...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) is funding the development of a Spotting-Free Nano-Oscillator Array (SFNOA) technology by Biosensing Instrument Inc. The SFNOA system aims to enable high-throughput, label-free quantification of ligand binding kinetics to transmembrane proteins in their native states. The $349,566 award, effective from April 2, 2025 to March 31, 2026,...
The National Institute of General Medical Sciences (NIGMS) awarded a $445,000 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) federal grant program to the Beckman Research Institute of the City of Hope. The grant, awarded on February 1, 2025, will fund research over a 5-year period until January 31, 2030. The key objectives of the project are to: Dissect the structural basis of allosteric modulation by the third intracellular loop (ICL3) of G protein-coupled...
The National Institute of General Medical Sciences (NIGMS) awarded a $349,816 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Narwhal Bio, Inc. in San Diego, CA. The grant supports the development of a prototype instrument, software, and consumable for non-invasive live-cell identification, tagging, and downstream characterization. This novel platform aims to enable researchers to study clinically relevant cell-cell interactions that drive diseases like...
The U.S. National Institute of General Medical Sciences (NIGMS) awarded a $213,563.00 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to The Regents of the University of Colorado, effective September 5, 2024 through August 31, 2026. The grant funds research to develop a new class of "shape-shifting" cyclic peptides that can rapidly assume diverse structural isomers, allowing them to interact with multiple biological targets. The project aims to create a...
The National Institute of General Medical Sciences (NIGMS) awarded a $917,454 Project Grant under CFDA 93.859, Biomedical Research and Research Training, to Integral Molecular Inc. The grant supports the development of a novel Membrane Proteome Array (MPA) technology for specificity screening and profiling of biotherapeutics like monoclonal antibodies and CAR-T cell therapies. The MPA represents 93% of the human extracellular proteome expressed in native conformation, providing a more...
The National Institute of General Medical Sciences (NIGMS) awarded Vanderbilt University a $395,943 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) with a performance period from September 1, 2024 to August 31, 2029. The goal of this research program is to develop new spectroscopic methods capable of providing enhanced insight into protein structure and dynamics within complex environments that impact human health. The key products and services to be...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $400,530 to the University of Virginia to develop next-generation "designer nanodiscs" to probe and reprogram membrane biology. The goal is to advance the understanding of how cell membranes regulate the structure, function, and dynamics of proteins involved in key cellular processes like membrane fusion, exosome...